1. Home
  2. INOD vs PVLA Comparison

INOD vs PVLA Comparison

Compare INOD & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innodata Inc.

INOD

Innodata Inc.

HOLD

Current Price

$42.23

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$122.94

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INOD
PVLA
Founded
1988
2015
Country
United States
United States
Employees
3000
14
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
INOD
PVLA
Price
$42.23
$122.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
15
Target Price
$100.00
$171.87
AVG Volume (30 Days)
975.8K
205.7K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
3.37
N/A
EPS
0.92
N/A
Revenue
$86,775,000.00
N/A
Revenue This Year
$38.42
N/A
Revenue Next Year
$27.03
$104,350.18
P/E Ratio
$47.16
N/A
Revenue Growth
9.84
N/A
52 Week Low
$31.95
$20.20
52 Week High
$93.82
$151.18

Technical Indicators

Market Signals
Indicator
INOD
PVLA
Relative Strength Index (RSI) 48.46 49.67
Support Level $42.04 $108.99
Resistance Level $47.22 $133.53
Average True Range (ATR) 2.86 6.87
MACD 0.62 -0.41
Stochastic Oscillator 53.12 42.79

Price Performance

Historical Comparison
INOD
PVLA

About INOD Innodata Inc.

Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: